Icafolin-methyl: our data predicts the winners and losers in the herbicide market
Summary
A new non-selective herbicide mode of action is reaching the market for the first time in more than 30 years. Bayer's Icafolin-methyl is already reshaping strategic conversations across the crop protection industry — before a single unit has been sold.
As glyphosate resistance continues to expand and established chemistries face mounting pressure, the arrival of Icafolin-methyl raises urgent questions for every stakeholder in the herbicide value chain: What does this molecule displace? How will it affect pricing and portfolio strategy? Which markets will move first?
Drawing on Kynetec's proprietary farmer insights and long-term market intelligence, our Icafolin-methyl report delivers the answers you need to act before launch.
Report Structure (Available may 2026)
Four strategic modules. One complete picture.
What is Icafolin-methyl and why does it represent a genuine breakthrough? This module covers the molecule's mechanism of action, agronomic fit, and target crop segments.
Where does Icafolin fit within existing herbicide portfolios? Which resistance challenges does it address, and which current products or chemistries could be displaced?
Regulatory roadmap, registration timeline, and launch forecast by geography. Rollout scenarios by market priority and competitive intensity.
How will Icafolin's entry reshape pricing, margins, and competitive dynamics? Detailed premium scenarios and operational implications for distributors and manufacturers.
KYNETEC EXPERT
"Icafolin-methyl represents the first genuinely new non-selective herbicide mode of action since the 1980s. Its arrival will create opportunities — and threats — for every player in the crop protection value chain."
- Full strategic report (PDF)
- Clear frameworks and scenarios
- Action-oriented recommendations
- Built for strategy, marketing, portfolio, pricingand commercial teams
- How the industry should prepare
- Recommended steps for retailers, agronomistsand growers
- Pricing and premium scenarios
- Operational implications
Case Studies
Impact and results